Simon Dixon is a Cardiology physician affiliated with Beaumont Hospital. OpenAlex indexes 19 publications with 457 citations (h-index 7); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3601 W 13 Mile Rd
3rd Floor Heart Center
Royal Oak, MI 480736712
Telephone
248-898-4163Provider last certified this registry record 21 Oct 2020.
Clinical trials
- Reduce Radiation Exposure in Fluoroscopic Interventions Evaluation
Sponsor: Corewell Health East
- Near-Infrared Spectroscopy and Ultrasound Investigation of Coronary Artery Plaque
Sponsor: Corewell Health East
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20252 payments
- Abbott LaboratoriesProgram year20241 payment
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
85.3%Statin19.4%Rosuvastatin Calcium65%Atorvastatin Calcium33%Pravastatin Sodium2%Part D<11 patientsBeta blocker14.5%Metoprolol Succinate45%Carvedilol36%Metoprolol Tartrate17%Nadolol2%Part D<11 patients+ 15 more classes in this area
Blood & clotting
10.8%Factor Xa inhibitor5.3%Eliquis90%Xarelto11%Part D≥67 patientsP2Y12 inhibitor5.1%Clopidogrel92%Brilinta8%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
3.6%SGLT2 inhibitor2.1%Jardiance84%Farxiga16%Part D<11 patientsPotassium supplement0.7%Potassium Chloride100%Part D≥12 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Novel risk score for patients undergoing Impella-assisted high-risk percutaneous coronary intervention
Cardiovascular revascularization medicine
2025 - Identifying Surfaces for ex vivo expansion of conjunctiva
Investigative Ophthalmology & Visual Science
2019
Similar KOLs
Other experts from the same institution or the same specialty.
John P. Burke
Beaumont Hospital
Gilbert Raff
Beaumont Hospital
Robert Safian, MD
Beaumont Hospital
Michael A. Farrell
Beaumont Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”